Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Purpose The purpose of the study was to determine the effectiveness of megestrol acetate (MA) and olanzapine (OLN) for the treatment of cancer-related anorexia (CRA). Methods Eighty adult patients with advanced gastrointestinal cancer or lung cancer (stages III and IV) with CRA (loss of appetite and greater than or equal to 5% loss of preillness stable weight) were randomized to receive daily MA or MA plus OLN for a period of 8 weeks. Patients were assessed weekly using the M.D. Anderson Symptom Inventory with specific measurement of weight, appetite, nausea, and quality of life (QOL) measures. Results For the 37 patients receiving MA, 15 patients had a greater than or equal to 5% weight gain, 2 patients had an appetite improvement, 3 patients had an improvement in nausea, and 5 patients had an improvement in QOL at both 4 and 8 weeks. For the 39 patients receiving MA plus OLN, 33 patients had a greater than or equal to 5% weight gain, 25 patients had an appetite improvement, 21 patients had an improvement in nausea, and 23 patients had an improvement in QOL at both 4 and 8 weeks, and there was an improvement in general activity, mood, work, walking, and enjoyment at 8 weeks. There were no grade III or IV treatment-related toxicities in patients receiving MA or the combination of MA plus OLN. Conclusions The combination of MA and OLN appears to be an effective intervention for patients with CRA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The improvement in appetite is not surprising, as the appetite-enhancing properties of this drug are well known.14”
From Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial (2020) · cites this paper as [14]
Citations
Cites
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 1×
“QOL was measured using a reliable and valid 28-item self-report instrument called the Functional Assessment of Cancer Therapy-General (version 3) [17].”
MethodAssessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P., & Wong, D. T. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00129-n · Cited by 1,062
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 669
Cancer cachexia: Developing multimodal therapy for a multidimensional problem
Fearon, K. C. H. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.033 · Cited by 444
Tranmer, J. E., Heyland, D., Dudgeon, D., Groll, D., Squires-Graham, M., & Coulson, K. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00074-5 · Cited by 259
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
Yavuzsen, T., Davis, M. P., Walsh, D., LeGrand, S., & Lagman, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8010 · Cited by 240
New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment
Goldstein, L. E., Sporn, J., Brown, S., Kim, H., Finkelstein, J., Gaffey, G. K., Sachs, G., & Stern, T. A. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71210-7 · Cited by 220
Weight effects associated with antipsychotics: A comprehensive database analysis
Parsons, B., Allison, D. B., Loebel, A., Williams, K., Giller, E., Romano, S., & Siu, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.025 · Cited by 191
Evaluation of nutritional status in advanced metastatic cancer
Sarhill, N., Mahmoud, F. A., Walsh, D., Nelson, K. A., Kömürcü, Ş., Davis, M. P., LeGrand, S. B., Abdullah, O., & Rybicki, L. A. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0486-0 · Cited by 171
Passik, S. D., Lundberg, J., Kirsh, K. L., Theobald, D., Donaghy, K., Holtsclaw, E., Cooper, M., & Dugan, W. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00391-3 · Cited by 154
Navari, R. M., Einhorn, L. H., Loehrer, P. J., Passik, S. D., Vinson, J., McClean, J., Chowhan, N. M., Hanna, N. H., & Johnson, C. S. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0248-5 · Cited by 151
Self-citationNavari, R. M., Einhorn, L. H., Passik, S. D., Loehrer, P. J., Johnson, C. S., Mayer, M. L., McClean, J., Vinson, J., & Pletcher, W. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-004-0755-6 · Cited by 147
Self-citationPotent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine
Bymaster, F. P., Falcone, J. F., Bauzon, D., Kennedy, J. S., Schenck, K. W., DeLapp, N. W., & Cohen, M. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01399-1 · Cited by 122
Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Srivastava, M., Brito-Dellan, N., Davis, M. P., Leach, M., & Lagman, R. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00143-x · Cited by 106 · cited 2×
“The improvement in nausea with the use of OLN in this patient population has been previously reported [15, 18, 19].”
MethodThibault, R., Goujon, N., Le Gallic, E., Clairand, R., Sébille, V., Vibert, J., Schneider, S. M., & Darmaun, D. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.01.003 · Cited by 99 · cited 1×
“It is unlikely that the measurement of weight would be affected by an unblinded study, and the use of visual analog scales has been demonstrated to be very accurate in the measurement of appetite [20, 21] and nausea [13, 14].”
BackgroundOlanzapine for intractable nausea in palliative care patients.
Jackson, W. C., & Tavernier, L. (2003) · Journal of Palliative Medicine · doi:10.1089/109662103764978506 · Cited by 78 · cited 2×
“The improvement in nausea with the use of OLN in this patient population has been previously reported [15, 18, 19].”
MethodJatoi, A., Kumar, S. K., Sloan, J. A., & Nguyen, P. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.180 · Cited by 65
Hale, A. S. (1997) · PubMed · Cited by 32
Jatoi, A. (2006) · PubMed · Cited by 21
The Impact of Test Medium on Use of Visual Analogue Scales
Woods, C. A., & Cumming, B. (2008) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0b013e3181909b03 · Cited by 17
Research works printed but not linked: 1
- Hale AS (1997) Olanzapine. Br J Hosp Med 58:443–445
Cited by
Lung cancer: Biology and treatment options
Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y.-W., & Buchanan, P. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.002 · Cited by 1,014
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
“Olanzapine is an atypical antipsychotic drug acting on multiple receptors, including dopamine and serotonin receptors, both of which are potentially relevant in cachexia.(99) In clinical use, olanzapine causes more weight gain than other antipsychotic drugs.”
BackgroundInfluentialMegestrol acetate for treatment of anorexia-cachexia syndrome
Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub3 · Cited by 293
Pathophysiology of anorexia in the cancer cachexia syndrome
Ezeoke, C. C., & Morley, J. E. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12059 · Cited by 225
Metadata
- Authors
- Navari, R. M., & Brenner, M. C.
- Affiliations
- University of Notre Dame (US)
- Corresponding author
- Navari, Rudolph M.
- ORCID
- Navari, Rudolph M.
- Venue
- Supportive Care in Cancer
- Published
- 2009-09-11
- Volume
- 18
- Issue
- 8
- Pages
- 951-956
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2080945325
- Semantic Scholar
- d7f344105e53ad56408e6f55d10be97846130e96
- Cited by
- 99
- References
- 21
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 14 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 3 · 2013: 5 · 2012: 14
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Supportive Care in Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Walther Cancer Foundation
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- cancer-related anorexia, megestrol acetate, olanzapine, combination therapy, weight gain, appetite, nausea, quality of life, gastrointestinal cancer, lung cancer, advanced cancer, symptom management
- MeSH terms
- Olanzapine, Adult, Aged, Aged, 80 and over, Anorexia, Appetite, Benzodiazepines, Body Weight, Drug Therapy, Combination, Female, Gastrointestinal Neoplasms, Humans, Lung Neoplasms, Male, Middle Aged, Nausea, Neoplasm Staging, Quality of Life, Selective Serotonin Reuptake Inhibitors, Appetite Stimulants, Megestrol Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.